期刊文献+

中药治疗湿性老年性黄斑变性临床观察 被引量:29

Clinical study on therapy in wet age-related macular degeneration by traditional Chinese medicine
下载PDF
导出
摘要 目的观察凉血化瘀法对湿性老年性黄斑变性(age-relatedmaculardegeneration,AMD)的临床疗效。方法确诊为湿性AMD患者46例78只眼,观察治疗前后对患者的视力、眼底照相、荧光素眼底血管造影、OCT检查情况。结果62只眼治疗后视力有不同程度提高,黄斑区出血吸收并停止反复出血,随访4个月~2年,病情均无反复,视力015~03,其中31例患者51只眼行荧光素眼底血管造影和OCT检查,发现有39只眼脉络膜新生血管缩小,总有效率532%。结论中医药对AMD有较好的治疗作用,但尚需科学设计、长期随访。 OBJECTIVE In order to observe the clinical effect of liangxuehuayu recipe on wet age-related macular degeneration(AMD).METHODS Observe the alteration fundus lesions of pre-treatment and post-treatment by fundus color photography,fundus fluorescein angiography (FFA) and OCT in the 78 eyes of 46 patients with wet AMD.RESULTS We found in clinical that liangxuehuayu recipe could promote visual acuity,absorption of macular hemorrhage,atrophy of CNV.The effective rate is 53.2%.CONCLUSION The traditional Chinese medicine could be effect for treatment of AMD,but still need scientific design and long period follow-up.
出处 《中国中医眼科杂志》 2005年第1期2-4,共3页 China Journal of Chinese Ophthalmology
基金 国家自然科学基金(30472229)
关键词 老年性黄斑变性 中药 凉血化瘀 age-related macular degeneration,AMD the traditional Chinese medicine liangxuehuayu(凉血化瘀)
  • 相关文献

参考文献9

  • 1张承芬,李志清,杜虹,韩宝铃.年龄相关性黄斑变性合并脉络膜新生血管患者的自然病程和视力预后[J].中华眼科杂志,2003,39(7):415-418. 被引量:25
  • 2王萧,胡世兴.老年性黄斑变性的研究进展[J].眼科学报,2001,17(4):245-251. 被引量:10
  • 3翁维良 主编.活血化瘀治疗疑难病[M].北京:学苑出版社,2003.593-594.
  • 4Bird A C, Bressler N M, Bressler S B, et al. An international classification and grading system for age - selated maculopathy and age - related maculardegeneration [J] .Surv Ophthalmol, 1995, 39 (5): 367-374.?A
  • 5Klein R, Klein B E, Linton K L.Prevalence of age- related maculopathy [J] .Ophthalmology, 1992, 99 (6): 933-943.?A
  • 6Wormald R, Evans J, Smeeth L.Photodynamic therapy for neovascular age- related macular degeneration [ J ] . Cochrane Database Syst Rev,2000, 20 (2): 20.?A
  • 7DnsaiRP, CiullaTA, PrattLM, et al.Intravitreal triamcinolone acetonide in exudative age- related macular degeneration [ J] .Retina,2000, 20 (3): 244-250.?A
  • 8Yasukawa T, Kimura H, Tabata Y, et al. Active drug targeting with immunoconjugates to choroidal neovascularization [ J] . Curr Eye Res,2000, 21 (6): 952-961.?A
  • 9Honda M, Sakamoto T, Ishibashi T, et al. Experimental subretinal neovascularization is inhibited by adenovirus - mediated soluble VEGF/flt - 1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age - related macular degeneration [ J ] . Gene Ther, 2000, 7(11): 978-985.?A

二级参考文献39

  • 1张承芬.眼底荧光血管造影[A].张承芬 主编.眼底病学[C].北京:人民卫生出版社,1998.88-117.
  • 2[1]Leibowitz H, Krrueger D, Maunder L, et al: The Framingham Eye Study monogragh: An ophthalmological and epidemiological study of cataract , glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults. 1973-1975. Surv Ophthalmol 1980; 24:335 ~ 610.
  • 3[2]Evans J, Wormald R: Is the incidence of registrable agerelated macular degeneration increasing? Br J Opht 1996; 80: 9.
  • 4[4]Klein R, Klein B, Linton K: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99:9333 ~ 9943.
  • 5[5]Schachat A P, Hyman L, Leshe M C, et al: Features of AEMD in a black population. Arch-Opht, 1995; 113: 728.
  • 6[7]Seddon J M, Ajani U A, Sperduto R D, et al: Riskfactors for ARMD. The eye disease case control study group. Arch Opht 1992; 110: 1701.
  • 7[8]Pagliarini S, Moramarco A, Wormald RPL, et al:Age-related macular disease in rural southern Italy. Arch Opht 1997; 115: 616.
  • 8[9]Mare Pertman J A, Brady W E, Klein R, et al: Dietary fat and age-related maculopathy. Arch Opht 1995; 113: 743.
  • 9[10]Gottsch J D, Pou S, Bynone L A: Hematogenous photosensitization: a mechanism for the development of macular degeneration. Inve Opht Vis Sci 1990; 31: 1674.
  • 10[11]Mitchell P, Smith W, Attebo K, Wang J J: Prevalence of age related maculopathy in Australia, the Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450.

共引文献33

同被引文献282

引证文献29

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部